1. Hematological Toxicity of Hypofractionated Radiotherapy: A Review of the Available Evidence
   Mateusz Spałek et al, 2018, Oncology Research and Treatment CrossRef
2. Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome
   Eva Hlavackova et al, 2019, Frontiers in Oncology CrossRef
3. The role of dendritic cells in neuroblastoma: Implications for immunotherapy
   Rasa Zafari et al, 2022, Immunobiology CrossRef
4. Radiotherapy and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors in Renal Cancer
   Michele Fiore et al, 2018, Chemotherapy CrossRef
5. Rapid recruitment and IFN-I–mediated activation of monocytes dictate focal radiotherapy efficacy
   Sirimuvva Tadepalli et al, 2023, Science Immunology CrossRef
6. Targets for improving tumor response to radiotherapy
   Keywan Mortezaee et al, 2019, International Immunopharmacology CrossRef
7. Approaches for boosting antitumor immunity in prostate cancer therapy: A comprehensive review on drugs, products, and nanoparticles
   Diandian Chen et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
8. Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity
   Stefano Arcangeli et al, 2019, Critical Reviews in Oncology/Hematology CrossRef